[{"address1": "11555 Sorrento Valley Road", "address2": "Suite 203", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "619 941 0360", "fax": "619 941 0361", "website": "https://www.aethlonmedical.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.", "fullTimeEmployees": 15, "irWebsite": "http://aethlonmedical.investorroom.com/about", "maxAge": 86400, "priceHint": 4, "previousClose": 0.59, "open": 0.6, "dayLow": 0.575, "dayHigh": 0.62, "regularMarketPreviousClose": 0.59, "regularMarketOpen": 0.6, "regularMarketDayLow": 0.575, "regularMarketDayHigh": 0.62, "beta": 1.607, "forwardPE": -0.17068376, "volume": 1869441, "regularMarketVolume": 1869441, "averageVolume": 4328388, "averageVolume10days": 9903780, "averageDailyVolume10Day": 9903780, "bid": 0.588, "ask": 0.5973, "bidSize": 1500, "askSize": 1500, "marketCap": 3043260, "fiftyTwoWeekLow": 0.37, "fiftyTwoWeekHigh": 5.0, "priceToSalesTrailing12Months": 5.299585, "fiftyDayAverage": 0.9096, "twoHundredDayAverage": 1.62745, "currency": "USD", "enterpriseValue": -5392188, "floatShares": 2561990, "sharesOutstanding": 5079720, "sharesShort": 1752964, "sharesShortPriorMonth": 29759, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.66660005, "heldPercentInsiders": 0.03342, "heldPercentInstitutions": 0.010299999, "shortRatio": 1.28, "shortPercentOfFloat": 0.67440003, "impliedSharesOutstanding": 5079730, "bookValue": 2.931, "priceToBook": 0.20440122, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -12249691, "trailingEps": -5.01, "forwardEps": -3.51, "lastSplitFactor": "1:10", "lastSplitDate": 1696464000, "enterpriseToRevenue": -9.39, "enterpriseToEbitda": 0.473, "52WeekChange": -0.84210527, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "AEMD", "underlyingSymbol": "AEMD", "shortName": "Aethlon Medical, Inc.", "longName": "Aethlon Medical, Inc.", "firstTradeDateEpochUtc": 920557800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "66b9f885-0b09-302d-b962-5780d51313cc", "messageBoardId": "finmb_683712", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.5991, "targetHighPrice": 10.0, "targetLowPrice": 3.5, "targetMeanPrice": 6.75, "targetMedianPrice": 6.75, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 7972012, "totalCashPerShare": 3.042, "ebitda": -11402972, "totalDebt": 1009943, "quickRatio": 3.795, "currentRatio": 3.927, "totalRevenue": 574245, "debtToEquity": 13.269, "revenuePerShare": 0.236, "returnOnAssets": -0.47157001, "returnOnEquity": -0.98429, "freeCashflow": -5872016, "operatingCashflow": -10511084, "grossMargins": 1.0, "operatingMargins": -20.47164, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]